01 3Cytec Industries Inc.
01 3Docusate Sodium
01 3Belgium
NDC Package Code : 60378-100
Start Marketing Date : 2001-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 60378-050
Start Marketing Date : 2001-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 60378-085
Start Marketing Date : 2001-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.85kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Docusate Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Docusate Potassium, including repackagers and relabelers. The FDA regulates Docusate Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Docusate Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Docusate Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Docusate Potassium supplier is an individual or a company that provides Docusate Potassium active pharmaceutical ingredient (API) or Docusate Potassium finished formulations upon request. The Docusate Potassium suppliers may include Docusate Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Docusate Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Docusate Potassium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Docusate Potassium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Docusate Potassium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Docusate Potassium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Docusate Potassium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Docusate Potassium suppliers with NDC on PharmaCompass.
We have 1 companies offering Docusate Potassium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?